Corteva completes spin‑off of seed and genetics business to become pure‑play crop protection company
Corteva Inc. announced that it has finalized the separation of its seed and genetics unit, leaving the company focused solely on crop protection. CEO Luke Kissam said the move gives the firm greater focus, agility and a renewed commitment to innovation. The crop‑protection segment added more than $1 billion of revenue and expanded EBITDA margins by about 250 basis points between 2020 and 2025. Corteva highlighted an $11 billion pipeline and plans to launch 12 new active ingredients, including five biologicals, over the next decade.
Why it matters
The spin‑off creates a pure‑play crop‑protection business, which may sharpen the company’s strategic focus and could be viewed positively by investors seeking exposure to that segment. The announced pipeline and margin expansion suggest potential upside for future earnings, according to the company’s statements.
Key facts
- 1Corteva completed the spin‑off of its advanced seed and genetics business. prnewswire.com
- 2The crop‑protection segment added more than $1 billion in revenue from 2020 to 2025. prnewswire.com
- 3Operating EBITDA margins in the crop‑protection segment expanded by approximately 250 basis points over the same period. prnewswire.com
- 4Corteva plans to launch 12 new active ingredients, including 5 biological products, over the next decade. prnewswire.com
- 5The company’s crop‑protection pipeline is valued at $11 billion. prnewswire.com
- 6Differentiated technologies now represent about 65 % of sales. prnewswire.com
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.